Predominance of spliceosomal complex formation over polyadenylation site selection in TDP-43 autoregulation

Nucleic Acids Research

Volumn 42, Issue 5, 2014, Pages 3362-3371

  Bembich, Sara ^a   Herzog, Jeremias S ^a   De Conti, Laura ^a   Stuani, Cristiana ^a   Avendaño Vázquez, S Eréndira ^a,b   Buratti, Emanuele ^a   Baralle, Marco ^a   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TAR DNA BINDING PROTEIN;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; AUTOREGULATION; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION REGULATION; INTRON; MOLECULAR RECOGNITION; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SPLICEOSOME;

CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; HEK293 CELLS; HOMEOSTASIS; HUMANS; INTRONS; POLYADENYLATION; RNA SPLICE SITES; RNA SPLICING; RNA TRANSPORT; RNA, MESSENGER; RNA-BINDING PROTEINS; SPLICEOSOMES;

EID: 84898999228     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1343     Document Type: Article

References (43)

1. Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science, 319, 916-919. (Pubitemid 351263754
2. Douglas, P.M. and Dillin, A. (2010) Protein homeostasis and aging in neurodegeneration. J. Cell Biol., 190, 719-729.
3. Dai, W., Zhang, G. and Makeyev, E.V. (2012) RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res., 40, 787-800.
4. Wollerton, M.C., Gooding, C., Wagner, E.J., Garcia-Blanco, M.A. and Smith, C.W. (2004) Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsensemediated decay. Mol. Cell, 13, 91-100.
5. Rossbach, O., Hung, L.H., Schreiner, S., Grishina, I., Heiner, M., Hui, J. and Bindereif, A. (2009) Auto-And cross-regulation of the hnRNP L proteins by alternative splicing. Mol. Cell. Biol., 29, 1442-1451.
6. McGlincy, N.J., Tan, L.Y., Paul, N., Zavolan, M., Lilley, K.S. and Smith, C.W. (2010) Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay. BMC Genomics, 11, 565.
7. Le Guiner, C., Lejeune, F., Galiana, D., Kister, L., Breathnach, R., Stevenin, J. and Del Gatto-Konczak, F. (2001) TIA-1 and TIAR activate splicing of alternative exons with weak 50 splice sites followed by a U-rich stretch on their own pre-mRNAs. J. Biol. Chem., 276, 40638-40646.
8. Jumaa, H. and Nielsen, P.J. (1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J., 16, 5077-5085. (Pubitemid 27348416
9. Sureau, A., Gattoni, R., Dooghe, Y., Stevenin, J. and Soret, J. (2001) SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J., 20, 1785-1796. (Pubitemid 32299414
10. Stoilov, P., Daoud, R., Nayler, O. and Stamm, S. (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum. Mol. Genet., 13, 509-524.
11. Buratti, E. and Baralle, F.E. (2011) TDP-43: New aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease. FEBS J., 278, 3530-3538.
12. Yap, K. and Makeyev, E.V. (2013) Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms. Mol. Cell. Neurosci., 56, 420-428.
13. Maquat, L.E. (2005) Nonsense-mediated mRNA decay in mammals. J. Cell Sci., 118, 1773-1776. (Pubitemid 40723821
14. Ayala, Y.M., De Conti, L., Avendano-Vazquez, S.E., Dhir, A., Romano, M., D'Ambrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E. et al. (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J., 30, 277-288.
15. Avendano-Vazquez, S.E., Dhir, A., Bembich, S., Buratti, E., Proudfoot, N. and Baralle, F.E. (2012) Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev., 26, 1679-1684.
16. Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F. and Gaynor, R.B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol., 69, 3584-3596.
17. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M. and Baralle, F.E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J., 20, 1774-1784. (Pubitemid 32299413
18. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602-611.
19. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133. (Pubitemid 44547757
20. Buratti, E. and Baralle, F.E. (2012) TDP-43: Gumming up neurons through protein-protein and protein-RNA interactions. Trends Biochem. Sci., 37, 237-247.
21. Halliday, G., Bigio, E.H., Cairns, N.J., Neumann, M., Mackenzie, I.R. and Mann, D.M. (2012) Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects. Acta Neuropathol., 124, 373-382.
22. Buratti, E. and Baralle, F.E. (2009) The molecular links between TDP-43 dysfunction and neurodegeneration. Adv. Genet., 66, 1-34.
23. Lee, E.B., Lee, V.M. and Trojanowski, J.Q. (2012) Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci., 13, 38-50.
24. Xu, Z.S. (2012) Does a loss of TDP-43 function cause neurodegeneratioñMol. Neurodegener., 7, 27.
25. Arnold, E.S., Ling, S.C., Huelga, S.C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H.B., McAlonis-Downes, M., Platoshyn, O., Parone, P.A. et al. (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. USA, 110, E736-E745.
26. Guo, W., Chen, Y., Zhou, X., Kar, A., Ray, P., Chen, X., Rao, E.J., Yang, M., Ye, H., Zhu, L. et al. (2011) An ALS-Associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol., 18, 822-830.
27. Bhardwaj, A., Myers, M.P., Buratti, E. and Baralle, F.E. (2013) Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res., 41, 5062-5074.
28. Kornblihtt, A.R. (2007) Coupling transcription and alternative splicing. Adv. Exp. Med. Biol., 623, 175-189.
29. Yeo, G. and Burge, C.B. (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol., 11, 377-394.
30. Reese, M.G., Eeckman, F.H., Kulp, D. and Haussler, D. (1997) Improved splice site detection in Genie. J. Comput. Biol., 4, 311-323.
31. Huang, C., Xia, P.Y. and Zhou, H. (2010) Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime. Int. J. Biol. Sci., 6, 396-406.
32. Disset, A., Michot, C., Harris, A., Buratti, E., Claustres, M. and Tuffery-Giraud, S. (2005) A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD) Hum. Mutat., 25, 72-81. (Pubitemid 40075916
33. Buratti, E. and Baralle, F.E. (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol., 7, 420-429.
34. Buratti, E., Romano, M. and Baralle, F.E. (2013) TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls. Mol. Cell. Neurosci., 56, 465-474.
35. Moisse, K., Volkening, K., Leystra-Lantz, C., Welch, I., Hill, T. and Strong, M.J. (2009) Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury. Brain Res., 1249, 202-211.
36. Swarup, V., Audet, J.N., Phaneuf, D., Kriz, J. and Julien, J.P. (2012) Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis. J. Neurosci., 32, 18186-18195.
37. Sato, T., Takeuchi, S., Saito, A., Ding, W., Bamba, H., Matsuura, H., Hisa, Y., Tooyama, I. and Urushitani, M. (2009) Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons. Neuroscience, 164, 1565-1578.
38. Kanazawa, M., Kakita, A., Igarashi, H., Takahashi, T., Kawamura, K., Takahashi, H., Nakada, T., Nishizawa, M. and Shimohata, T. (2011) Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats. J. Neurochem., 116, 957-965.
39. Johnson, V.E., Stewart, W., Trojanowski, J.Q. and Smith, D.H. (2011) Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans. Acta Neuropathol., 122, 715-726.
40. Budini, M. and Buratti, E. (2011) TDP-43 autoregulation: Implications for disease. J. Mol. Neurosci., 45, 473-479.
41. Smith, C.W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: The logic of combinatorial control. Trends Biochem. Sci., 25, 381-388.
42. Buratti, E., Baralle, M. and Baralle, F.E. (2006) Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res., 34, 3494-3510.
43. Roca, X., Krainer, A.R. and Eperon, I.C. (2013) Pick one, but be quick: 50 splice sites and the problems of too many choices. Genes Dev., 27, 129-144.